Tangible Shareholders Equity: The value shareholders equity less intangible assets.
Pacific Biosciences of California, Inc. (PACB) had Tangible Shareholders Equity of $-200.74M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$154.01M |
|
$-309.85M |
|
$116.73M |
|
$37.28M |
|
$628.33M |
|
$-474.31M |
|
$164.78M |
|
$-309.54M |
|
$-309.54M |
|
$-309.85M |
|
$-309.85M |
|
$-309.85M |
|
$-309.85M |
|
$-474.31M |
|
$-249.51M |
|
274.49M |
|
288.37M |
|
$-1.13 |
|
$-1.59 |
|
| Balance Sheet Financials | |
$495.68M |
|
$30.50M |
|
$764.77M |
|
$1.26B |
|
$66.30M |
|
$647.49M |
|
$687.55M |
|
$753.85M |
|
$506.59M |
|
|
Tangible Shareholders Equity |
$-200.74M |
$506.59M |
|
294.42M |
|
| Cash Flow Statement Financials | |
$-206.06M |
|
$124.00M |
|
$-42.99M |
|
$182.63M |
|
$57.59M |
|
$-125.04M |
|
$71.04M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.48 |
|
-- |
|
-- |
|
0.56 |
|
1.28 |
|
24.21% |
|
-307.97% |
|
-307.97% |
|
-162.00% |
|
-200.98% |
|
-201.18% |
|
$-212.25M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
1.99 |
|
5.60 |
|
65.23 |
|
-61.16% |
|
154.36% |
|
-24.58% |
|
-26.85% |
|
$1.72 |
|
$-0.74 |
|
$-0.71 |
|